Accelerate Diagnostic - Cv 5.0%

Historical Holders from Q2 2023 to Q3 2025

Type / Class
Debt / Cv 5.0%
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal
$0
Total reported market value
$0
Principal change
-$3,292,574
Market value change
-$658,515
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Accelerate Diagnostic - Cv 5.0% across Reporting Periods

Period Principal Value Change Price (% of par) Investors
2025 Q3 $0 $0 -$658,515 0
2025 Q2 $3,292,574 $658,515 -$19,379,226 20.0% 1
2025 Q1 $45,839,284 $20,696,043 +$4,945,321 20.0% 5
2024 Q4 $47,884,428 $17,158,033 +$1,239,713 20.01% 7
2024 Q3 $35,720,689 $16,839,333 -$846,091 39.68% 6
2024 Q2 $45,563,508 $15,909,159 +$1,708,322 40.0% 7
2024 Q1 $29,829,667 $16,675,545 $0 67.06% 5
2023 Q4 $34,008,227 $22,686,790 +$19,066,052 66.25% 6
2023 Q3 $3,055,000 $3,055,000 $0 100.0% 1
2023 Q2 $3,055,000 $3,055,000 +$3,055,000 100.0% 1